MSM Corporation International Ltd

MSM Corporation ups its game with new enhancements to talent contest

Eight-time Grammy award winner Usher is the platform’s chief creative director.

A stage performer
In August, the company raised $10.5 million in new capital

MSM Corporation International Ltd (ASX:MSM) has made a further set of enhancements to its flagship app-based talent contest Megastar Millionaire.

The company has successfully scaled its back-end infrastructure to handle over a million daily active users engaging in the competition, anticipating strong user growth in the coming months.

Megastar Millionaire is a global app-based talent contest that promotes social media artists in a series of competitions conducted over multi-month time spans.

The Megastar platform is a constantly evolving technology ecosystem designed to incorporate a globally scalable cloud infrastructure.

MSM recently enhanced the livestreaming feature for all users to include gifting and other engagement mechanics, building on the livestreaming feature which was added in July 2017.

This aligns Megastar’s user experience with massively successful mobile entertainment platforms like Twitch, the world's leading video and community platform for gamers.

The user experience has also been upgraded to enable performers to upload videos directly from their mobile phone to the Megastar competition.

In August, the company raised $10.5 million in new capital and appointed eight-time Grammy award winner Usher as Megastar’s chief creative director, ambassador and mentor of the competition.

The company has now completed the process of integrating Usher into the competition.

Quick facts: MSM Corporation International Ltd

Price: $0.01

Market: ASX
Market Cap: $10.85 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Kazia Therapeutics reaches milestone for Phase 1 Cantrixil trial in ovarian...

Kazia Therapeutics Limited (ASX:KZA) chief executive officer Dr James Garner updates Proactive Investors on a milestone for the company, with the completion of recruitment for Cantrixil its Phase 1 clinical trial in ovarian cancer. The CEO said the first part of the study has shown some very...

52 minutes ago

2 min read